Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLOROX CO /DE/ Director's Dealing 2018

Apr 4, 2018

30403_dirs_2018-04-04_82a64c90-3311-48d3-9b2f-400aa3b4d289.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2018-04-01

Reporting Person: Jacobsen Kevin B (SVP - Chief Financial Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2402.0000 Direct
Common Stock 40.0000 Indirect
Common Stock 24.0000 Indirect
Common Stock 3126.0000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $84.4500 2023-09-17 Common Stock (3585.0000) Direct
Stock Option (Right to Buy) $89.8200 2024-09-17 Common Stock (15630.0000) Direct
Stock Option (Right to Buy) $111.6000 2025-09-17 Common Stock (11410.0000) Direct
Stock Option (Right to Buy) $123.0900 2026-09-13 Common Stock (10920.0000) Direct
Stock Option (Right to Buy) $135.5700 2027-09-12 Common Stock (9830.0000) Direct

Footnotes

F1: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date.